Using Micro Flow Imaging (MFI) to Measure Protein Aggregation
White Paper Jan 08, 2018
Sub-visible particles are a critical quality attribute for pharmaceutical products, as protein aggregates can elicit an immunogenic response that affects the therapeutic's efficacy.
Measuring protein aggregation is a common way to get an indication of stability, and MFI is widely used in formulation studies and stability studies where aggregation measurements are needed.
Download this free white paper from Protein Simple to learn about the differences between MFI and how MFI provides crucial information about your protein therapeutic.
Related White Papers
8 Reasons why it’s Time to Upgrade to Automated ImagingWhite Paper
Why automated image analysis is rapidly replacing manual microscopy for characterizing particle shape and how combining it with Raman spectroscopy adds chemical identification.READ MORE
7 Key Factors When Considering a Benchtop X-ray DiffractometerWhite Paper
In this white paper, our marketing director of the America’s Kathy Macchiarola outlines the important decisions factors that are key requirements and help you select a benchtop system ideal for your situation and your needs.READ MORE
Supporting the Pharmaceutical Industry with 21 CFR Part 11 Compliance ReadinessWhite Paper
The purpose of this document is to describe how PANalytical systems support system owners meeting the requirements of the 21 CFR Part 11 regulations issued by the United States’ FDA.READ MORE
Like what you just read? You can find similar content on the communities below.Analysis & Separations Biopharma Cell Science Drug Discovery Informatics Proteomics & Metabolomics Immunology & Microbiology
To personalize the content you see on Technology Networks homepage, Log In or Subscribe for FreeLOGIN SUBSCRIBE FOR FREE
9th International Conference on Mass Spectrometry and Chromatography
Sep 21 - Sep 22, 2018